Pathogen News and Research

RSS

Specific immune signature identified in COVID-19 patients

Researchers at King’s College London and collaborators have identified an “immune signature” that could help researchers better understand coronavirus disease 2019 (COVID-19) and serve as a valuable resource for predicting patient prognosis and informing clinical risk-based stratification.

10 Jun 2020

Virologists develop new methods to inactivate and study SARS-Cov-2

Detailed methods on how to perform research on SARS-CoV-2, the virus that causes COVID-19, including procedures that effectively inactivate the virus to enable the safe study of infected cells have been identified by virologists in the Institute for Biomedical Sciences at Georgia State University.

10 Jun 2020

KFU research group finds ways to disrupt protein synthesis in Staphylococcus aureus

It is well known that many strains of Staphylococcus are resistant to antibiotics, and research groups around the world seek new targets in the bacteria to decrease their infectious potential.

9 Jun 2020

Re-trafficking proteins to defend against Salmonella infections

When humans get infected by pathogenic bacteria, the body's immune system tries to eliminate the intruders.

9 Jun 2020

Researchers examine bat genome assemblies to find solution for COVID-19

While questions remain about the origin of COVID-19, many scientists now believe the virus spread to humans from bats. Two Texas Tech University researchers are now taking a closer look at whether bats also could offer a solution to the pandemic.

9 Jun 2020

COVID-19 produces lung inflammation in non-human primate experiments

A new study published on the online preprint server bioRxiv in June 2020 reports the successful use of three primate species to model the infection, pathogenesis, and clinical features associated with COVID-19. The research provides useful and immediately available models to test new vaccines and treatments.

9 Jun 2020

DNA sequencing and analysis of drug-resistant bacteria set up in the Philippines

Antibiotic resistance surveillance in the Philippines has moved into the genomic era, enabling better tracking of dangerous bacteria. Researchers at the Centre for Genomic Pathogen Surveillance (CGPS housed at the Wellcome Sanger Institute and The Big Data Institute, University of Oxford), and the Philippine Research Institute for Tropical Medicine, set up local DNA sequencing and analysis of drug resistant bacteria in the Philippines.

5 Jun 2020

Rational use of antibiotics can help fight bacterial infections

The increase in antibiotic resistance and the lack of new antibiotics is currently a major global health problem.

5 Jun 2020

Designing a prototype spike protein vaccine for SARS-CoV-2

A recent study published on the preprint server bioRxiv in June 2020 reports the development of a prototype vaccine containing multiple antigenic sites, based on the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is causing the current COVID-19 pandemic. If successful, this could lead to the development of an effective, non-allergenic vaccine that induces both humoral and cellular immunity.

4 Jun 2020

New research focuses on protein-coding gene's role in inflammatory bowel disease

A protein-coding gene associated with autoimmune diseases such as Crohn's disease and ulcerative colitis, collectively referred to as inflammatory bowel disease, or IBD, will be the focus of new research in the School of Medicine at the University of California, Riverside.

4 Jun 2020

JGU professor wins Exploration Grant for research into membrane proteins of parasites

So-called neglected tropical diseases (NTDs) cause great suffering in some of the world's poorest countries and can lead also to significant economic losses due to, for example, the infestation of animal herds.

4 Jun 2020

Hesperos’ immune system-on-a-chip emulates immune reactions for tissue damage and acute inflammation

Hesperos Inc., pioneers of the Human-on-a-Chip in vitro system, today announced the publication of a new peer-reviewed publication that describes how the company’s technology can be used to investigate immune responses following treatment with biological therapeutics for multi-organ systemic diseases, including cancer, infectious diseases and inflammatory disorders.

4 Jun 2020

Beckman Coulter Life Sciences’ RNAdvance Viral XP kit listed for use in EUA-authorized COVID-19 testing

Beckman Coulter Life Sciences today announced RNAdvance Viral XP has been added to the list of acceptable extraction methods for use in the Centers for Disease Control’s EUA-authorized COVID-19 test referenced in the FDA’s FAQ on testing for SARS-CoV-2. Laboratories are now permitted to independently validate RNAdvance Viral XP for use.

From Beckman Coulter Life Sciences 4 Jun 2020

Tumors cause disruption of the immune system throughout the body, study finds

Cancer treatment has advanced with the advent of immunotherapies that, in some cancers, can overcome tumors' ability to evade the immune system by suppressing local immune responses.

3 Jun 2020

Octapharma extends support for COVID-19 study following promising preliminary data

Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.

3 Jun 2020

Changes in land use may influence the spread of diseases

The quest to discover how new diseases - such as Covid-19 - emerge and spread in response to global land-use change driven by human population expansion still contains "major gaps", researchers have claimed.

3 Jun 2020

Cats resistant to SARS-CoV-2 reinfection

Researchers at Colorado State University have made important discoveries about domestic cats infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could address concerns about human-to-animal transmission and the role domestic pets might play in spreading the virus.

2 Jun 2020

Scientists to develop device to identify neutralizing antibodies against SARS-CoV-2 infection

A Texas A&M University team of scientists and engineers is leading the development of a device that can be used to rapidly identify antibodies produced by human B cells that can neutralize infection by SARS-CoV-2, the causative agent of COVID-19.

2 Jun 2020

Human waste could be used to create nitrogen-rich fertilizer

Researchers from Cornell University's College of Agriculture and Life Sciences and the Canadian Light Source at the University of Saskatchewan have proven it is possible to create nitrogen-rich fertilizer by combining the solid and liquid components of human waste.

2 Jun 2020

NAU scientist collaborating on vault-based vaccine to prevent and treat COVID-19

C. Todd French, assistant professor of biology and leader of Northern Arizona University's new COVID-19 Testing Service Center, is working with scientists at Vault Pharma, an emerging biotechnology company, to test candidate vaccines against the novel coronavirus.

1 Jun 2020

Pathogen News and Research

Specific immune signature identified in COVID-19 patients

Virologists develop new methods to inactivate and study SARS-Cov-2

KFU research group finds ways to disrupt protein synthesis in Staphylococcus aureus

Re-trafficking proteins to defend against Salmonella infections

Researchers examine bat genome assemblies to find solution for COVID-19

COVID-19 produces lung inflammation in non-human primate experiments

DNA sequencing and analysis of drug-resistant bacteria set up in the Philippines

Rational use of antibiotics can help fight bacterial infections

Designing a prototype spike protein vaccine for SARS-CoV-2

New research focuses on protein-coding gene's role in inflammatory bowel disease

JGU professor wins Exploration Grant for research into membrane proteins of parasites

Hesperos’ immune system-on-a-chip emulates immune reactions for tissue damage and acute inflammation

Beckman Coulter Life Sciences’ RNAdvance Viral XP kit listed for use in EUA-authorized COVID-19 testing

Tumors cause disruption of the immune system throughout the body, study finds

Octapharma extends support for COVID-19 study following promising preliminary data

Changes in land use may influence the spread of diseases

Cats resistant to SARS-CoV-2 reinfection

Scientists to develop device to identify neutralizing antibodies against SARS-CoV-2 infection

Human waste could be used to create nitrogen-rich fertilizer

NAU scientist collaborating on vault-based vaccine to prevent and treat COVID-19

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News